Neil Kumar, Director, Chief Executive Officer, on August 18, 2026, sold 44,980 shares in Bridgebio Pharma (BBIO) for $3,727,251. Following the Form 4 filing with the SEC, Kumar has control over a total of 5,067,460 common shares of the company, with 243,327 shares held directly and 4,824,133 controlled indirectly.
SEC Filing: